신규 초음파 프로브를 이용한 로봇 보조 전립선 생검
새로운 초음파 프로브를 사용한 로봇 보조 전립선 생검
Prostate cancer (PCa) is the most diagnosed type of cancer and the second leading cause of cancer related deaths among US men, and its incidence has increased steadily in the last decade. Efforts to address the rise in PCa diagnosis without overdetection and overtreatment include targeted biopsy techniques for clinically significant PCa using magnetic resonance imaging (MRI), and precision targeted biopsy guided by ultrasound and fused to the MRI.
The study aims to improve prostate biopsy with a novel ultrasound probe and robot developed at Johns Hopkins, the ProBot device. The trial is a Phase 1 clinical trial to evaluate the safety and feasibility of the new device.
ProBot is an entirely new concept including a novel ultrasound probe and robot kinematics specifically designed for the prostate. It operates with only two degrees of freedom configured such that the motions for 3D image scanning and biopsy may not deform the prostate gland, thus improving the accuracy of MRI-ultrasound fusion and needle targeting at biopsy.
ProBot is a small and lightweight robot (1.3Kg including the ultrasound probe). It allows hands-free operation of its ultrasound probe at 3D image scanning and needle targeting supervised by the urologist.
In addition to MRI-targeted biopsy (TB), at systematic biopsy (SB), instead of using the common template plan that is the same for all patients, the innovative software optimizes the plan for each patient to obtain a diagnosis that is representative of the whole gland histology. The ProBot robot is also uniquely capable of transrectal (TR) and transperineal (TP) biopsy.
The aims of the study are to determine the safety and feasibility of the new device at TR and TP biopsies.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 1단계
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Rana Harb
- 전화번호: 410-502-5500
- 이메일: rharb1@jhmi.edu
연구 연락처 백업
- 이름: Sara A Naizghi
- 전화번호: 720-965-9494 4105501980
- 이메일: snaizgh1@jh.edu
연구 장소
-
-
Maryland
-
Baltimore, Maryland, 미국, 21287
- 모병
- Johns Hopkins Hospital
-
연락하다:
- Rana Harb
- 전화번호: 410-502-5500
- 이메일: rharb1@jhmi.edu
-
연락하다:
- Sara A Naizghi
- 전화번호: 720-965-9494
- 이메일: snaizgh1@jh.edu
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Included in the study will be:
-
Men between the ages of 40 and 75
-
Men must have one of the following "high risk" features:
- PSA > 4.0 ng/ml and/or abnormal digital rectal examination (DRE)
- ASAP (atypical small acinar proliferation) on previous biopsy
-
Men with mpMRI or bpMRI exams, including both PI-RADS ≤2 and PI-RADS ≥3.
Excluded from the study will be patients without available mpMRI exams and patients:
-
Females and children because of the prostate cancer targeted disease.
-
Patients who are not recommended or in whom TR or TP prostate biopsy is considered high-risk:
- Patients with previous rectal surgery.
- Patients with anal stenosis or coagulopathy.
- Patients on active anticoagulation medication (eg. Coumadin, Lovenox, or Heparin).
- Patients who cannot tolerate periprostatic Lidocaine block anesthesia or in whom anesthesia is considered high-risk.
-
Patients who already had a prostate biopsy taken with the ProBot investigational device.
-
Vulnerable populations, such as prisoners, institutionalized individuals.
-
Patients who are unwilling or unable to sign informed consent (no assent required).
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 장치 타당성
- 할당: 무작위화되지 않음
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Transrectal biopsy (TR)
Biopsy guided by transrectal ultrasound fused with MRI and needle inserted on a transrectal path |
Precision personalized prostate biopsy with a novel ultrasound probe and robot, ProBot |
|
실험적: Transperineal biopsy (TP)
Biopsy guided by transrectal ultrasound fused with MRI and needle inserted on a transperineal path. |
Precision personalized prostate biopsy with a novel ultrasound probe and robot, ProBot |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Device feasibility as assessed by patient discomfort score
기간: Immediately after the procedure
|
Scale 1-10, 10 highest discomfort |
Immediately after the procedure
|
|
Device feasibility as assessed by maximal procedural pain
기간: Immediately after the procedure
|
Scale 1-10, 10 highest pain |
Immediately after the procedure
|
|
Device feasibility as assessed by the rate of complications
기간: Throughout the study, each case recorded within 1 month of the procedure
|
Rate of complications |
Throughout the study, each case recorded within 1 month of the procedure
|
|
Device feasibility as assessed by serious adverse events
기간: Up to 1 month post procedure
|
Serious Adverse events throughout the study |
Up to 1 month post procedure
|
|
Device feasibility as assessed by the rate of successful completion of cases
기간: Immediately post procedure
|
Rate of cases completed successfully throughout the study |
Immediately post procedure
|
|
Device feasibility as assessed by the procedure time
기간: Immediately post procedure
|
Times of the procedures measured in minutes throughout the study |
Immediately post procedure
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Prostate cancer detection rates at targeted biopsy (TB)
기간: Up to 1 month post procedure
|
Clinically significant PCa detection rates at TB throughout the study |
Up to 1 month post procedure
|
|
Prostate cancer detection rates at systematic biopsy (SB)
기간: Up to one month post procedure
|
Clinically significant PCa detection rates at SB throughout the study |
Up to one month post procedure
|
|
Needle targeting errors
기간: Immediately post procedure
|
Measured in ultrasound throughout the study |
Immediately post procedure
|
|
Prostate deformations (mm)
기간: Immediately post procedure
|
Maximum deformation of the gland between the start and end of the procedure measured in [mm] throughout the study |
Immediately post procedure
|
|
Prostate displacement (mm)
기간: Immediately post procedure
|
Displacement of the gland between the start and end of the procedure measured in [mm] throughout the study |
Immediately post procedure
|
공동 작업자 및 조사자
협력자
협력자
수사관
수사관
- 수석 연구원: Misop Han, MD, Johns Hopkins University
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- IRB00229568
- R01CA303859 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .